{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:33:54Z","timestamp":1792460034571,"version":"4.5.0"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Photodynamic therapy (PDT) is an established local treatment for actinic keratoses, Bowen disease, and selected low-risk basal cell carcinomas, but its potential to reshape antitumor immunity may extend its value beyond direct phototoxicity. We conducted a narrative synthesis of clinical, translational, and mechanistic evidence, supplemented by targeted searches through August 2026, and appraised major findings using a three-level evidence-maturity framework. Current evidence supports a temporally organized model in which PDT-induced reactive oxygen species promote tumor and microvascular injury, immunogenic cell death, damage-associated molecular pattern release, tumor-antigen exposure, innate immune-cell recruitment, dendritic-cell activation, and subsequent T-cell priming. This early immune-priming phase may be followed by suppressive feedback involving hypoxia, tumor-associated macrophages, regulatory T cells, myeloid-derived suppressor cells, PD-1\/PD-L1 signaling, and IL-10\/TGF-\u03b2. Evidence maturity and translational relevance vary across cutaneous neoplasms: clinical use is best established for actinic keratoses, Bowen disease, and superficial or selected low-risk basal cell carcinomas, whereas PDT-based immunotherapy combinations in invasive cutaneous squamous cell carcinoma and melanoma remain predominantly preclinical or exploratory. In cSCC models, ALA-PDT combined with PD-L1 blockade improved control of primary and distant tumors, providing preclinical support for further translational evaluation of checkpoint-based combinations. Preclinical timing studies further suggest that combination efficacy may depend on aligning checkpoint blockade with the post-PDT T-cell activation window. Photosensitizer localization, fluence, irradiance, oxygenation, and treatment schedule may likewise determine whether PDT favors immunogenic priming or excessive tissue injury and suppressive rebound. These findings position PDT as a parameter-tunable local immune-priming platform whose clinical translation should integrate indication-specific selection, treatment-parameter optimization, temporal immune monitoring, rationally timed combination therapy, and prospective clinical validation.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1931149","type":"journal-article","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:00:10Z","timestamp":1788868810000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Photodynamic therapy remodels cutaneous tumor immunity: innate priming, suppressive feedback, and translational opportunities"],"prefix":"10.3389","volume":"17","author":[{"given":"Yang","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Dermatology, The Fifth People\u2019s Hospital of Hainan Province","place":["Haikou, China"]},{"name":"Hainan Medical University","place":["Haikou, Hainan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The Fifth People\u2019s Hospital of Hainan Province","place":["Haikou, China"]},{"name":"Hainan Medical University","place":["Haikou, Hainan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiejie","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The Fifth People\u2019s Hospital of Hainan Province","place":["Haikou, China"]},{"name":"Department of Dermatology, Affiliated Dermatology Hospital of Hainan Medical University","place":["Haikou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The Fifth People\u2019s Hospital of Hainan Province","place":["Haikou, China"]},{"name":"Department of Dermatology, Affiliated Dermatology Hospital of Hainan Medical University","place":["Haikou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13091332","article-title":"Photodynamic therapy review: principles, photosensitizers, applications, and future directions","volume":"13","author":"Correia","year":"2021","journal-title":"Pharmaceutics"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16017","article-title":"European dermatology forum guidelines on topical photodynamic therapy 2019 part 1: treatment delivery and established indications - actinic keratoses, bowen\u2019s disease and basal cell carcinomas","volume":"33","author":"Morton","year":"2019","journal-title":"J Eur Acad Dermatol Venereol: JEADV"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001926","article-title":"Targeting immunogenic cancer cell death by photodynamic therapy: past, present and future","volume":"9","author":"Alzeibak","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2019-000337","article-title":"Consensus guidelines for the definition, detection and interpretation of immunogenic cell death","volume":"8","author":"Galluzzi","year":"2020","journal-title":"J Immunother Cancer"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.830208","article-title":"Key players of the immunosuppressive tumor microenvironment and emerging therapeutic strategies","volume":"10","author":"Park","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-023-03479-3","article-title":"TGF-\u03b21 mediates tumor immunosuppression aggravating at the late stage post-high-light-dose photodynamic therapy","volume":"72","author":"Han","year":"2023","journal-title":"Cancer Immunol Immunother CII"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1375767","article-title":"Enhancing cancer immunotherapy with photodynamic therapy and nanoparticle: making tumor microenvironment hotter to make immunotherapeutic work better","volume":"15","author":"Thiruppathi","year":"2024","journal-title":"Front Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s41073-019-0064-8","article-title":"SANRA\u2014a scale for the quality assessment of narrative review articles","volume":"4","author":"Baethge","year":"2019","journal-title":"Res Integrity Peer Rev"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/s41419-020-03221-2","article-title":"Detection of immunogenic cell death and its relevance for cancer therapy","volume":"11","author":"Fucikova","year":"2020","journal-title":"Cell Death Dis"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-1778","article-title":"Photodynamic therapy enhancement of antitumor immunity is regulated by neutrophils","volume":"67","author":"Kousis","year":"2007","journal-title":"Cancer Res"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0560.2008.01063.x","article-title":"Sequential effects of photodynamic treatment of basal cell carcinoma","volume":"36","author":"Prignano","year":"2009","journal-title":"J Cutan Pathol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1995.108","article-title":"Induction of immune cell infiltration into murine SCCVII tumour by photofrin-based photodynamic therapy","volume":"71","author":"Krosl","year":"1995","journal-title":"Br J Cancer"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1335920","article-title":"The impact of photodynamic therapy on immune system in cancer \u2013 an update","volume":"15","author":"Dudzik","year":"2024","journal-title":"Front Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1586\/eci.10.81","article-title":"Stimulation of anti-tumor immunity by photodynamic therapy","volume":"7","author":"Mroz","year":"2011","journal-title":"Expert Rev Clin Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6600864","article-title":"Role of cytokines in photodynamic therapy-induced local and systemic inflammation","volume":"88","author":"Gollnick","year":"2003","journal-title":"Br J Cancer"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1172\/JCI143759","article-title":"Neutrophil dynamics in the tumor microenvironment","volume":"131","author":"McFarlane","year":"2021","journal-title":"J Clin Invest"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.741305","article-title":"Tumor-associated macrophages and their functional transformation in the hypoxic tumor microenvironment","volume":"12","author":"He","year":"2021","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-0400","article-title":"Enhanced systemic immune reactivity to a basal cell carcinoma associated antigen following photodynamic therapy","volume":"15","author":"Kabingu","year":"2009","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"B19","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3892\/ol.2024.14505","article-title":"Increased CD56 expression after photodynamic therapy indicates an increased natural killer cell count following early photodynamic therapy for cutaneous squamous cell carcinoma","volume":"28","author":"Zhao","year":"2024","journal-title":"Oncol Lett"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jphotobiol.2015.10.027","article-title":"Effect of 5-ALA-mediated photodynamic therapy on mast cell and microvessels densities present in oral premalignant lesions induced in rats","volume":"153","author":"Rosin","year":"2015","journal-title":"J Photochem Photobiol B"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.70599","article-title":"Nanoparticle-mediated cuproptosis and photodynamic synergistic strategy: a novel horizon for cancer therapy","volume":"14","author":"Zhang","year":"2025","journal-title":"Cancer Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/s41419-022-04851-4","article-title":"Which cell death modality wins the contest for photodynamic therapy of cancer","volume":"13","author":"Mishchenko","year":"2022","journal-title":"Cell Death Dis"},{"key":"B23","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41392-024-01801-8","article-title":"The gasdermin family: emerging therapeutic targets in diseases","volume":"9","author":"Zhu","year":"2024","journal-title":"Signal Transduction Targeted Ther"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-008054","article-title":"Mitochondria-targeted photodynamic therapy triggers GSDME-mediated pyroptosis and sensitizes anti-PD-1 therapy in colorectal cancer","volume":"12","author":"Zhou","year":"2024","journal-title":"J Immunother Cancer"},{"key":"B25","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s10103-024-04218-5","article-title":"Necroptosis as a consequence of photodynamic therapy in tumor cells","volume":"39","author":"de Souza","year":"2024","journal-title":"Lasers Med Sci"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70010","article-title":"Ferroptosis: mechanisms and therapeutic targets","volume":"5","author":"Zhou","year":"2024","journal-title":"MedComm"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e28942","article-title":"A review on ferroptosis and photodynamic therapy synergism: enhancing anticancer treatment","volume":"10","author":"Chang","year":"2024","journal-title":"Heliyon"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1126\/science.abf0529","article-title":"Copper induces cell death by targeting lipoylated TCA cycle proteins","volume":"375","author":"Tsvetkov","year":"2022","journal-title":"Sci (N Y NY)"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2003.04898.x","article-title":"Histological changes and involvement of apoptosis after photodynamic therapy for actinic keratoses","volume":"148","author":"Nakaseko","year":"2003","journal-title":"Br J Dermatol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2023.119603","article-title":"Modified 5-aminolevulinic acid photodynamic therapy induces cutaneous squamous cell carcinoma cell pyroptosis via the JNK signaling pathway","volume":"1871","author":"Chen","year":"2024","journal-title":"Biochim Biophys Acta (BBA) - Mol Cell Res"},{"key":"B31","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/lsm.10190","article-title":"Necrotic and apoptotic cell death of human Malignant melanoma cells following photodynamic therapy using an amphiphilic photosensitizer, ATX-S10(Na)","volume":"33","author":"Nagata","year":"2003","journal-title":"Lasers Surg Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2023.122212","article-title":"Exosome camouflaged coordination-assembled iridium(III) photosensitizers for apoptosis-autophagy-ferroptosis induced combination therapy against melanoma","volume":"301","author":"Feng","year":"2023","journal-title":"Biomaterials"},{"key":"B33","doi-asserted-by":"publisher","first-page":"664","DOI":"10.3892\/ol.2021.12925","article-title":"Inhibition of photodynamic therapy induced-immunosuppression with aminolevulinic acid leads to enhanced outcomes of tumors and pre-cancerous lesions","volume":"22","author":"Bayless","year":"2021","journal-title":"Oncol Lett"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13020210","article-title":"The functional crosstalk between myeloid-derived suppressor cells and regulatory T cells within the immunosuppressive tumor microenvironment","volume":"13","author":"Haist","year":"2021","journal-title":"Cancers"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2022.2061396","article-title":"PD-L1 blockade potentiates the antitumor effects of ALA-PDT and optimizes the tumor microenvironment in cutaneous squamous cell carcinoma","volume":"11","author":"Zeng","year":"2022","journal-title":"Oncoimmunology (2022)"},{"key":"B36","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/s41392-024-01979-x","article-title":"Cold and hot tumors: from molecular mechanisms to targeted therapy","volume":"9","author":"Wu","year":"2024","journal-title":"Signal Transduction Targeted Ther"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-03-3513","article-title":"Choice of oxygen-conserving treatment regimen determines the inflammatory response and outcome of photodynamic therapy of tumors","volume":"64","author":"Henderson","year":"2004","journal-title":"Cancer Res"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2020.592941","article-title":"Subcellular singlet oxygen and cell death: location matters","volume":"8","author":"Liang","year":"2020","journal-title":"Front Chem"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.pdpdt.2021.102392","article-title":"The induction of immunogenic cell death by photodynamic therapy in B16F10 cells in vitro is effected by the concentration of the photosensitizer","volume":"35","author":"Morais","year":"2021","journal-title":"Photodiagn Photodyn Ther"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.836397","article-title":"Advances in photodynamic therapy based on nanotechnology and its application in skin cancer","volume":"12","author":"Zhang","year":"2022","journal-title":"Front Oncol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2023.113252","article-title":"European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma: part 2. Treatment-update 2023","volume":"193","author":"Stratigos","year":"2023","journal-title":"Eur J Cancer"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2023.113254","article-title":"European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma-update 2023","volume":"192","author":"Peris","year":"2023","journal-title":"Eur J Cancer"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13143484","article-title":"Light technology for efficient and effective photodynamic therapy: a critical review","volume":"13","author":"Algorri","year":"2021","journal-title":"Cancers"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-024-02844-y","article-title":"Fractionated photoimmunotherapy stimulates an anti-tumour immune response: an integrated mathematical and in vitro study","volume":"131","author":"Zahid","year":"2024","journal-title":"Br J Cancer"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.19897","article-title":"European consensus-based interdisciplinary guideline for diagnosis, treatment and prevention of actinic keratoses, epithelial UV-induced dysplasia and field cancerization on behalf of European association of dermato-oncology, european dermatology forum, european academy of dermatology and venereology and union of medical specialists (union europ\u00e9enne des m\u00e9decins sp\u00e9cialistes)","volume":"38","author":"Kandolf","year":"2024","journal-title":"J Eur Acad Dermatol Venereol: JEADV"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.142.6.729","article-title":"Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or fluorouracil for treatment of squamous cell carcinoma In situ: results of a multicenter randomized trial","volume":"142","author":"Morton","year":"2006","journal-title":"Arch Dermatol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2024.115153","article-title":"European consensus-based interdisciplinary guideline for melanoma. Part 2: treatment - update 2024","volume":"215","author":"Garbe","year":"2025","journal-title":"Eur J Cancer"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1515\/hsz-2012-0228","article-title":"Melanoma resistance to photodynamic therapy: new insights","volume":"394","author":"Huang","year":"2013","journal-title":"Biol Chem"},{"key":"B49","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/j.1751-1097.2008.00436.x","article-title":"Optical properties of human melanocytic nevi in vivo","volume":"85","author":"Zonios","year":"2009","journal-title":"Photochem Photobiol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1529\/biophysj.105.075713","article-title":"Quantitative scattering of melanin solutions","volume":"90","author":"Riesz","year":"2006","journal-title":"Biophys J"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.pdpdt.2011.09.003","article-title":"Depigmentation in melanomas increases the efficacy of hypericin-mediated photodynamic-induced cell death","volume":"9","author":"Sharma","year":"2012","journal-title":"Photodiagn Photodyn Ther"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3390\/cells9112432","article-title":"Combination of photodynamic therapy and a flagellin-adjuvanted cancer vaccine potentiated the anti-PD-1-mediated melanoma suppression","volume":"9","author":"Hwang","year":"2020","journal-title":"Cells"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202200999","article-title":"Time rules the efficacy of immune checkpoint inhibitors in photodynamic therapy","volume":"9","author":"Wu","year":"2022","journal-title":"Adv Sci"},{"key":"B54","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1007\/s10120-023-01409-x","article-title":"Photodynamic therapy improves the outcome of immune checkpoint inhibitors via remodelling anti-tumour immunity in patients with gastric cancer","volume":"26","author":"Yu","year":"2023","journal-title":"Gastric Cancer: Off J Int Gastric Cancer Assoc Jpn Gastric Cancer Assoc"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.21781","article-title":"Clinical associations and classification of immune checkpoint inhibitor-induced cutaneous toxicities: a multicentre study from the European academy of dermatology and venereology task force of dermatology for cancer patients","volume":"187","author":"Nikolaou","year":"2022","journal-title":"Br J Dermatol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70143-8","article-title":"Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial","volume":"14","author":"Arits","year":"2013","journal-title":"Lancet Oncol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2013.580","article-title":"Photodynamic therapy plus regulatory T-cell depletion produces immunity against a mouse tumour that expresses a self-antigen","volume":"109","author":"Reginato","year":"2013","journal-title":"Br J Cancer"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-020-0410-2","article-title":"Clinical development and potential of photothermal and photodynamic therapies for cancer","volume":"17","author":"Li","year":"2020","journal-title":"Nat Rev Clin Oncol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1931149\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:00:11Z","timestamp":1788868811000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1931149\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,8]]},"references-count":58,"alternative-id":["10.3389\/fimmu.2026.1931149"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1931149","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,8]]},"article-number":"1931149"}}